These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
211 related items for PubMed ID: 16984283
1. Role of non-HLA genetic polymorphisms in graft-versus-host disease after haematopoietic stem cell transplantation. Bertinetto FE, Dall'Omo AM, Mazzola GA, Rendine S, Berrino M, Bertola L, Magistroni P, Caropreso P, Falda M, Locatelli F, Busca A, Amoroso A. Int J Immunogenet; 2006 Oct; 33(5):375-84. PubMed ID: 16984283 [Abstract] [Full Text] [Related]
2. Relation of an interleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell transplantation. Elmaagacli AH, Koldehoff M, Landt O, Beelen DW. Bone Marrow Transplant; 2008 May; 41(9):821-6. PubMed ID: 18209723 [Abstract] [Full Text] [Related]
3. Effect of donor CTLA-4 alleles and haplotypes on graft-versus-host disease occurrence in Tunisian patients receiving a human leukocyte antigen-identical sibling hematopoietic stem cell transplant. Sellami MH, Bani M, Torjemane L, Kaabi H, Ladeb S, Ben Othmane T, Hmida S. Hum Immunol; 2011 Feb; 72(2):139-43. PubMed ID: 21081144 [Abstract] [Full Text] [Related]
4. Interleukin-10 gene polymorphism in bone marrow transplant recipients. Azarpira N, Ramzi M, Aghdaie MH, Darai M, Geramizadeh B. Exp Clin Transplant; 2008 Mar; 6(1):74-9. PubMed ID: 18405249 [Abstract] [Full Text] [Related]
5. IL-6 and IL-10 promoter gene polymorphisms of patients and donors of allogeneic sibling hematopoietic stem cell transplants associate with the risk of acute graft-versus-host disease. Karabon L, Wysoczanska B, Bogunia-Kubik K, Suchnicki K, Lange A. Hum Immunol; 2005 Jun; 66(6):700-10. PubMed ID: 15993715 [Abstract] [Full Text] [Related]
6. IL2 and TNFA gene polymorphisms and the risk of graft-versus-host disease after allogeneic haematopoietic stem cell transplantation. Viel DO, Tsuneto LT, Sossai CR, Lieber SR, Marques SB, Vigorito AC, Aranha FJ, de Brito Eid KA, Oliveira GB, Miranda EC, de Souza CA, Visentainer JE. Scand J Immunol; 2007 Dec; 66(6):703-10. PubMed ID: 18021367 [Abstract] [Full Text] [Related]
9. Donor CD31 genotype and its association with acute graft-versus-host disease in HLA identical sibling stem cell transplantation. Goodman RS, Ewing J, Evans PC, Craig J, Poulton K, Dyer PA, Marcus RE, Taylor CJ. Bone Marrow Transplant; 2005 Jul; 36(2):151-6. PubMed ID: 15908974 [Abstract] [Full Text] [Related]
10. Molecular genetic analysis of interleukin-1 promoter and receptor antagonist tandem repeat polymorphisms among HLA-identical renal transplant recipient and donor pairs. Jin Y, Ruiz P. Transplant Proc; 2008 Jun; 40(5):1329-32. PubMed ID: 18589098 [Abstract] [Full Text] [Related]
11. NOD2 polymorphisms predict severe acute graft-versus-host and treatment-related mortality in T-cell-depleted haematopoietic stem cell transplantation. van der Velden WJ, Blijlevens NM, Maas FM, Schaap NP, Jansen JH, van der Reijden BA, Feuth T, Dolstra H, Donnelly JP. Bone Marrow Transplant; 2009 Aug; 44(4):243-8. PubMed ID: 19219079 [Abstract] [Full Text] [Related]
12. Relationship between cytokine gene polymorphisms and graft-versus-host disease after allogeneic stem cell transplantation in a Brazilian population. Laguila Visentainer JE, Lieber SR, Lopes Persoli LB, Dutra Marques SB, Vigorito AC, Penteado Aranha FJ, de Brito Eid KA, Oliveira GB, Martins Miranda EC, Bragotto L, de Souza CA. Cytokine; 2005 Nov 03; 32(3-4):171-7. PubMed ID: 16243534 [Abstract] [Full Text] [Related]
14. Association of vitamin D receptor polymorphisms with the outcome of allogeneic haematopoietic stem cell transplantation. Bogunia-Kubik K, Middleton P, Norden J, Dickinson A, Lange A. Int J Immunogenet; 2008 Jun 03; 35(3):207-13. PubMed ID: 18312595 [Abstract] [Full Text] [Related]
15. IL-10 promoter polymorphisms influence susceptibility to aGvHD and are associated with proportions of CD4+FoxP3+ lymphocytes in blood after hematopoietic stem cell transplantation. Jaskula E, Lange A, Dlubek D, Kyrcz-Krzemień S, Markiewicz M, Dzierzak-Mietla M, Jedrzejczak WW, Gronkowska A, Nowak J, Warzocha K, Hellmann A, Kowalczyk J, Drabko K, Goździk J, Mizia S, Polish Donor‐Recipient Matching Group. Tissue Antigens; 2013 Dec 03; 82(6):387-96. PubMed ID: 24498995 [Abstract] [Full Text] [Related]
16. Genetic polymorphisms predicting the outcome of bone marrow transplants. Dickinson AM, Middleton PG, Rocha V, Gluckman E, Holler E, Eurobank members. Br J Haematol; 2004 Dec 03; 127(5):479-90. PubMed ID: 15566351 [Abstract] [Full Text] [Related]
17. Polymorphisms of transforming growth factor-beta1 and transforming growth factor-beta1 type II receptor genes are associated with acute graft-versus-host disease in children with HLA-matched sibling bone marrow transplantation. Hattori H, Matsuzaki A, Suminoe A, Ihara K, Nagatoshi Y, Sakata N, Kawa K, Okamura J, Hara T. Bone Marrow Transplant; 2002 Nov 03; 30(10):665-71. PubMed ID: 12420205 [Abstract] [Full Text] [Related]
20. Protective role of interleukin-10 promoter gene polymorphism in the pathogenesis of invasive pulmonary aspergillosis after allogeneic stem cell transplantation. Seo KW, Kim DH, Sohn SK, Lee NY, Chang HH, Kim SW, Jeon SB, Baek JH, Kim JG, Suh JS, Lee KB. Bone Marrow Transplant; 2005 Dec 02; 36(12):1089-95. PubMed ID: 16247433 [Abstract] [Full Text] [Related] Page: [Next] [New Search]